title: Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy.
abstract: The aim of this paper was the application of the failure mode and effects analysis (FMEA) approach to assess the risks for patients undergoing radiotherapy treatments performed by means of a helical tomotherapy unit. FMEA was applied to the preplanning imaging, volume determination, and treatment planning stages of the tomotherapy process and consisted of three steps: 1) identification of the involved subprocesses; 2) identification and ranking of the potential failure modes, together with their causes and effects, using the risk probability number (RPN) scoring system; and 3) identification of additional safety measures to be proposed for process quality and safety improvement. RPN upper threshold for little concern of risk was set at 125. A total of 74 failure modes were identified: 38 in the stage of preplanning imaging and volume determination, and 36 in the stage of planning. The threshold of 125 for RPN was exceeded in four cases: one case only in the phase of preplanning imaging and volume determination, and three cases in the stage of planning. The most critical failures appeared related to (i) the wrong or missing definition and contouring of the overlapping regions, (ii) the wrong assignment of the overlap priority to each anatomical structure, (iii) the wrong choice of the computed tomography calibration curve for dose calculation, and (iv) the wrong (or not performed) choice of the number of fractions in the planning station. On the basis of these findings, in addition to the safety strategies already adopted in the clinical practice, novel solutions have been proposed for mitigating the risk of these failures and to increase patient safety.
authors.affiliation: Ospedale San Raffaele. broggi.sara@hsr.it.
authors.forename: Sara
authors.initials: S
authors.lastname: Broggi
authors.forename: Marie Claire
authors.initials: MC
authors.lastname: Cantone
authors.forename: Anna
authors.initials: A
authors.lastname: Chiara
authors.forename: Nadia
authors.initials: N
authors.lastname: Di Muzio
authors.forename: Barbara
authors.initials: B
authors.lastname: Longobardi
authors.forename: Paola
authors.initials: P
authors.lastname: Mangili
authors.forename: Ivan
authors.initials: I
authors.lastname: Veronese
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011446:Prospective Studies; D011832:Radiation Injuries / Q000517:prevention & control*; D011880:Radiotherapy Planning, Computer-Assisted; D050397:Radiotherapy, Intensity-Modulated; D018570:Risk Assessment; D012308:Risk Management
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):852-8
references.pmid: 19409731
references.citation: Med Phys. 2010 Aug;37(8):4133-7
references.pmid: 20879573
references.citation: Med Phys. 2010 Sep;37(9):4817-53
references.pmid: 20964201
references.citation: Ann ICRP. 2009 Aug;39(4):1-86
references.pmid: 20478472
references.citation: Risk Anal. 2007 Dec;27(6):1395-410
references.pmid: 18093042
references.citation: Radiat Oncol. 2013 May 24;8:127
references.pmid: 23705626
references.citation: J Appl Clin Med Phys. 2010 Dec 02;12(1):3371
references.pmid: 21330987
references.citation: Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):250-3
references.pmid: 20228050
references.citation: Radiother Oncol. 2008 Feb;86(2):231-41
references.pmid: 18061691
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e305-11
references.pmid: 21708432
references.citation: Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1324-9
references.pmid: 22197236
references.citation: Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S170-3
references.pmid: 18406920
references.citation: Radiother Oncol. 2010 Feb;94(2):129-44
references.pmid: 20153908
references.citation: Med Phys. 2010 Dec;37(12):6466-79
references.pmid: 21302802